Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stephanie Durso"'
Autor:
Jeffrey Lipman, Jason A. Roberts, Saurabh Pandey, Jeffery Loutit, Elizabeth Alexander, Suzanne L. Parker, Stephanie Durso, David E. Griffith, Nermin Karamujic, Steven C. Wallis, Fekade B. Sime
Publikováno v:
Antimicrobial Agents and Chemotherapy. 62
The combination product meropenem-vaborbactam, with activity against KPC-producing carbapenem-resistant Enterobacteriaceae, is likely to be used during renal replacement therapy. The aim of this work was to describe the extracorporeal removal (adsorp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::26cf1e9cdb9681be1299cac8a336d6ff
https://doi.org/10.1128/aac.01306-18
https://doi.org/10.1128/aac.01306-18
Autor:
Mark Redell, Cynthia Kennedy, Karen Fusaro, Stephanie Durso, Jeff Loutit, Greg Moeck, Christopher Lucasti, Michael N. Dudley
Publikováno v:
Open Forum Infectious Diseases
Background Oritavancin is a lipoglycopeptide used in the treatment of acute bacterial skin and skin structure infections (ABSSSIs) in adults. To characterize its use in patients in the postapproval setting, a patient registry was developed. Methods D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5b077cbc8fc4ae0cc2dd56c052deebd
https://pubmed.ncbi.nlm.nih.gov/29977954
https://pubmed.ncbi.nlm.nih.gov/29977954
Vaborbactam (formerly RPX7009) is a member of a new class of β-lactamase inhibitor with pharmacokinetic properties similar to those of many β-lactams, including carbapenems. The pharmacokinetics and safety of vaborbactam were evaluated in 80 health
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a620bf137627543fbd475e1051b7893b
https://europepmc.org/articles/PMC5038296/
https://europepmc.org/articles/PMC5038296/
Autor:
Eric Wenzler, Jeffrey S Loutit, Keith A. Rodvold, Michael N. Dudley, David C. Griffith, Stephanie Durso, Mark H. Gotfried
The steady-state concentrations of meropenem and the β-lactamase inhibitor RPX7009 in plasma, epithelial lining fluid (ELF), and alveolar macrophage (AM) concentrations were obtained in 25 healthy, nonsmoking adult subjects. Subjects received a fixe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d39896f43f50bc0c9bd723908ff83310
https://europepmc.org/articles/PMC4649232/
https://europepmc.org/articles/PMC4649232/
Autor:
Scott J. Hecker, K. Raja Reddy, Maxim Totrov, GavinC. Hirst, Olga Lomovskaya, David C. Griffith, Paula King, Ruslan Tsivkovski, Dongxu Sun, Mojgan Sabet, Ziad Tarazi, Matthew C. Clifton, Kateri Atkins, Amy Raymond, Kristy T. Potts, Jan Abendroth, Serge H. Boyer, Jeffrey S. Loutit, Elizabeth E. Morgan, Stephanie Durso
Publikováno v:
Journal of Medicinal Chemistry; May2015, Vol. 58 Issue 9, p3682-3692, 11p